Telix Pharmaceuticals Limited operates as a biotechnology company. The Company develops and commercializes molecularly-targeted radiation therapy for the treatment of prostate, renal, and brain cancer. Telix Pharmaceuticals serves patients worldwide.

Distribution Agreement with Isologic for Illuccix in Canada

Cleansing Notice under S708A(5)(e) Corporations Act 2001

Telix Pharmaceuticals - TLX AU

Description